Antiangiogenic combination therapy after local radiotherapy with topotecan radiosensitizer improved quality of life for children with inoperable brainstem gliomas

Acta Paediatr. 2011 Jan;100(1):134-8. doi: 10.1111/j.1651-2227.2010.01961.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Angiogenesis Inhibitors / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Brain Stem Neoplasms / pathology
  • Brain Stem Neoplasms / radiotherapy*
  • Celecoxib
  • Child
  • Child, Preschool
  • Disease Progression
  • Etoposide / administration & dosage
  • Glioma / pathology
  • Glioma / radiotherapy*
  • Humans
  • Pilot Projects
  • Pyrazoles / administration & dosage
  • Quality of Life
  • Radiation-Sensitizing Agents / therapeutic use*
  • Sulfonamides / administration & dosage
  • Survival Analysis
  • Thalidomide / administration & dosage
  • Topotecan / therapeutic use*
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Pyrazoles
  • Radiation-Sensitizing Agents
  • Sulfonamides
  • Thalidomide
  • Etoposide
  • Topotecan
  • Celecoxib